Register to use all the features of this website, including selecting clinical areas of interest and “favourite” articles, taking part in quizzes and much more.
Hint: If you are a General Practitioner your username may be your MCNZ#
About us | FAQ | Contact us | Terms of use
Interactive quizzes are based on material found in Best Practice Journal and Best Tests. Initially, quizzes are posted out with journals and GPs are invited to submit their answers for CME credits.
Register or Log in to take part in quizzes.
Login to my bpac.
Don't have an account? Register to use all the features of this website, including selecting clinical areas of interest, taking part in quizzes and much more.
The appropriate use of serum tumour marker testing is complex and patient harm can occur when testing is requested but not clinically... View Article
Follow-up and surveillance of patients who have undergone curative-intent treatment for gynaecological cancer is an opportunity... View Article
Vaginal cancer is the least common type of gynaecological cancer in New Zealand with an average of 17 females newly diagnosed... View Article
Vulval cancer is a rare gynaecological cancer in New Zealand, with an average of 52 females newly diagnosed each year (from 2015... View Article
Uterine cancer is the most prevalent gynaecological cancer in New Zealand, with an average of 627 females newly diagnosed each... View Article
Ovarian cancer is the second most common gynaecological cancer in New Zealand after endometrial cancer, with an average of 371... View Article
The risk of cervical cancer is significantly reduced through HPV vaccination and cervical screening programmes, however, there... View Article
Lesion thickness is the strongest predictor of prognosis in patients with a primary cutaneous melanoma. Therefore, identifying... View Article
Post-treatment follow-up and long-term surveillance of people with a history of melanoma improves the likelihood that recurrence... View Article
Transitioning from active treatment to post-treatment care is an important milestone in the long-term health of people who have... View Article
Guidance for following up people who have had polyps identified on colonoscopy and people with inflammatory bowel disease, who... View Article
Bowel cancer is a leading cause of cancer mortality in New Zealand, second only to lung cancer. Follow-up and surveillance of... View Article
Through improvements in diagnosis and treatment, one in three people in New Zealand with cancer now achieve sustained remission... View Article
Lung cancer is one of the most common cancers in New Zealand and the leading cause of cancer death. By the time of diagnosis,... View Article
This report provides an overview of laboratory prostate-specific antigen (PSA) testing in primary care to facilitate reflection,... View Article
Bowel cancer is one of the most common causes of cancer death in New Zealand. Approximately one-quarter of diagnoses are made... View Article
Testing for prostate cancer is a difficult issue as many prostate cancers are low risk and do not necessarily result in adverse... View Article
Biological medicines are an important advancement in the pharmaceutical treatment of patients with inflammatory and immunological... View Article
Limiting UV radiation exposure through sun smart behaviour is the key to preventing melanoma. However, incidence and mortality... View Article
Identification of melanoma at the earliest possible clinical stage improves outcomes; lesion thickness is the strongest predictor... View Article
Vaccination against human papillomavirus (HPV) infection provides safe and effective protection from genital warts, most cervical... View Article
Hereditary diffuse gastric cancer makes up around 1% of stomach cancer diagnoses, however, Māori in New Zealand are disproportionately... View Article
Kupe is freely available on the web and we would also like to make it available for general practitioners and practice nurses... View Article
Discussing the pros and cons of prostate cancer testing within a consultation can be challenging. To help General Practitioners... View Article
Immune checkpoint inhibitors, such as pembrolizumab (Keytruda), are new cancer treatments which are associated with a wide range... View Article
Fluorouracil and imiquimod creams are fully subsidised topical treatments, suitable for some patients with non-melanoma skin cancers;... View Article
View Article
Chemotherapy is predominantly managed in secondary care, but many prescriptions for oral medicines are dispensed and taken in... View Article
Vaccination against human papillomaviruses (HPV) is fully subsidised for girls and young women to reduce their risk of cervical... View Article
The New Zealand Laboratory Schedule provides clinicians with consistent guidance when considering requesting laboratory tests.... View Article
Acral melanoma is a subtype of cutaneous melanoma, which manifests on the palms, wrists and soles of the feet (including the nail... View Article
This article has been archived. If you would like access to the original article please contact: [email protected] View Article
Does aspirin protect against cancer? More high-quality research is needed View Article
When a patient presents with a suspicious skin lesion the first step is to assess the likelihood of melanoma being present and... View Article
A cervical smear test is an effective method for the early detection of cervical cancer, and for reducing cancer mortality. However,... View Article
Susan Reid and Carla White from health literacy and communication specialists, Workbase, explain how understanding and reducing... View Article
There are approximately 180 new diagnoses of cervical cancer in New Zealand each year. Having regular cervical smears can reduce... View Article
A urine dipstick positive for haematuria or proteinuria is a relatively common occurrence in primary care. For many patients there... View Article
Lung cancer in New Zealand: overcoming barriers View Article
Cancer services in New Zealand are undergoing major changes over the next few years. Primary care clinicians are likely to have... View Article
An ageing population, earlier diagnosis and advances in oncology treatment are contributing to a rising number of cancer survivors... View Article
What is a faecal occult blood test? When should a faecal occult blood test be requested? How should the results of a faecal... View Article
The incidence of colorectal cancer in New Zealand is high by international standards. New Zealand females have one of the highest... View Article
The human papillomavirus (HPV) vaccine was added to the national immunisation schedule in 2008 for females aged 12 years. The... View Article
The PHO Performance Programme was established in 2005 to improve the health of people enrolled in general practices in New Zealand... View Article
Serum protein bands (monoclonal gammopathy) will sometimes be found following serum protein electrophoresis in patients presenting... View Article
New Zealand has one of the highest rates of melanoma in the world. Melanoma is the most common cancer among New Zealand men aged... View Article
Significant progress has been made in increasing the rate of breast cancer screening in New Zealand. However, Māori women still... View Article
Cervical screening rates in New Zealand have continued to increase following the introduction of the National Cervical Screening... View Article
Prostate cancer screening in asymptomatic men is a controversial public health issue generating much debate with polarised views... View Article
GPs frequently perform tests for screening purposes, whether for formal screening programmes, such as cervical screening, or less... View Article
The key role for tumour marker tests is in managing patients with established malignancy. Tumour markers are not indicated as... View Article
Progress to date on a national screening programme for bowel cancer View Article
The majority of people with cancer will initially present to general practice, therefore GPs have an excellent opportunity to... View Article
Breast cancer is the leading cause of cancer death in New Zealand women. The national target for breast screening is for 70% of... View Article
Liquid-based cytology (LBC) and Human Papillomavirus (HPV) testing have recently been adopted to aid with the collection, diagnosis... View Article
After the introduction of the National Cervical Screening Programme, rates of cervical screening increased and the overall incidence... View Article
Gardasil vaccine has now been added to the National Immunisation Schedule. In this article we outline the eligibility criteria... View Article
Cancer has a significant and disproportionate impact on Māori, with significant disparities in experiences, quality of health... View Article
Imiquimod enhances the immune response to viral infections and tumours by stimulating the immune system to release interferon... View Article
Dr Nikki Turner is the Director of the Immunisation Advisory Centre. Here she provides us with an overview of the two currently... View Article
A focus on the clinical issues surrounding the use of Herceptin including latest results from clinical trials. View Article